- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 5/06 - Dipeptides
Détention brevets de la classe C07K 5/06
Brevets de cette classe: 807
Historique des publications depuis 10 ans
|
53
|
46
|
35
|
43
|
71
|
75
|
62
|
51
|
32
|
8
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Ajinomoto Co., Inc. | 2337 |
12 |
| MedImmune Limited | 627 |
12 |
| Novartis AG | 11238 |
11 |
| Ramot at Tel-Aviv University Ltd. | 1370 |
11 |
| Takeda Pharmaceutical Company Limited | 2961 |
9 |
| Medivir AB | 142 |
9 |
| Bristol-myers Squibb Company | 5080 |
7 |
| Cornell University | 3036 |
7 |
| NeoStrata Company, Inc. | 11 |
7 |
| Novartis Pharma GmbH | 350 |
7 |
| Suntory Holdings Limited | 1846 |
7 |
| Servier Pharmaceuticals, LLC | 95 |
7 |
| F. Hoffmann-La Roche AG | 7958 |
6 |
| The Regents of the University of California | 18943 |
6 |
| Onyx Therapeutics, Inc. | 71 |
6 |
| Tokyo Institute of Technology | 1367 |
6 |
| Genentech, Inc. | 3742 |
5 |
| Achillion Pharmaceuticals, Inc. | 176 |
5 |
| Apotex Technologies Inc. | 17 |
5 |
| Concortis Biosystems, Corp., a wholly owned subsidiary of Sorrento Therapeutics, Inc. | 5 |
5 |
| Autres propriétaires | 657 |